Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06278493 | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 34 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Feb 26, 2024 | clinicaltrials |
| NCT04177810 | Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer | completed | Phase 2 | 25 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 23, 2024 |
| clinicaltrials |
| NCT01673334 | Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms | completed | Phase 4 | 40 | University of VirginiaOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05161013 | A Proof-of-Concept Study Evaluating LINFU™ | completed | N/A | 12 | Adenocyte, LLCINDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06254430 | Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery | completed | — | 65 | Ankara City Hospital BilkentOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06267690 | A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC | completed | — | 295 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT04305067 | PRECISE: Pancreatic Cancer and Exercise | completed | N/A | 8 | Queen's University, BelfastOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06258824 | MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers(MIRABILE) | completed | — | 229 | Imperial College LondonOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT03834701 | Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms(RAPNEN) | completed | N/A | 60 | Catholic University of the Sacred HeartOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT01959139 | S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 126 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 9, 2024 | clinicaltrials |
| NCT04290364 | Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study(PanEffort-1) | completed | — | 74 | Inge Høgh DufvaOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT01525082 | Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors | completed | Phase 2 | 20 | Shaheen ShaguftaOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05074472 | A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors | completed | Phase 1 / Phase 2 | 35 | ZielBio, Inc.INDUSTRY | 1 | Jan 29, 2024 | clinicaltrials |
| NCT04066361 | OPTimizing Treatment Focused Genetic Testing IN Cancer(OPT-IN) | completed | N/A | 301 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 25, 2024 | clinicaltrials |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer(CAPANCOVID-19) | completed | — | 700 | CHU de ReimsOTHER | 1 | Jan 24, 2024 | clinicaltrials |
| NCT04330716 | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers(GeneBOPP) | completed | N/A | 269 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT04803305 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | completed | Phase 1 | 18 | PfizerINDUSTRY | 2 | Jan 12, 2024 | clinicaltrials |
| NCT04624217 | A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer | completed | Phase 1 / Phase 2 | 56 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma(NEOPAN) | completed | Phase 3 | 171 | UNICANCEROTHER | 1 | Jan 9, 2024 | clinicaltrials |
| NCT06195254 | Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer | completed | — | 19 | Peking University Third HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT04686747 | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment(COVID - AGICT) | completed | — | 2,000 | S.M. Misericordia HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT01825603 | ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer | completed | Phase 1 | 17 | University of NebraskaOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT05546970 | Efficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno-pancreatectomy(TAP-Block) | completed | — | 80 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT03340974 | Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 42 | Galera Therapeutics, Inc.INDUSTRY | 1 | Dec 15, 2023 | clinicaltrials |
| NCT02494037 | The Canadian/US Integrative Oncology Study(CUSIOS) | completed | — | 400 | The Canadian College of Naturopathic MedicineOTHER | 2 | Dec 14, 2023 | clinicaltrials |
| NCT04299048 | Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. | completed | Phase 1 | 11 | PfizerINDUSTRY | 1 | Dec 14, 2023 | clinicaltrials |
| NCT05589480 | Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection(PaC) | completed | — | 226 | Luo CongOTHER | 1 | Dec 11, 2023 | clinicaltrials |
| NCT03189914 | RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 46 | Processa PharmaceuticalsINDUSTRY | 1 | Dec 6, 2023 | clinicaltrials |
| NCT04237441 | The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT): | completed | — | 7,294 | Rigshospitalet, DenmarkOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT04893408 | Pancreatic Surgery in Elderly Patients | completed | — | 1,556 | Rigshospitalet, DenmarkOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT05595811 | Pancreatic and Periampullary Tumors in Greenland Inuit | completed | — | 2,326 | Rigshospitalet, DenmarkOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT06147154 | Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients | completed | — | 23 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT02381249 | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | completed | N/A | 40 | St. James's Hospital, IrelandOTHER | 2 | Nov 27, 2023 | clinicaltrials |
| NCT02231723 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | completed | Phase 1 | 139 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02703545 | International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs(CAPS Registry) | completed | — | 58 | Johns Hopkins UniversityOTHER | 0 | Nov 18, 2023 | clinicaltrials |
| NCT03784677 | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors | completed | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04596865 | Recurrence After Whipple's (RAW) Study | completed | — | 1,484 | University Hospital Plymouth NHS TrustOTHER | 8 | Nov 18, 2023 | clinicaltrials |
| NCT02527434 | Study of Tremelimumab in Patients With Advanced Solid Tumors | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 5 | Nov 15, 2023 | clinicaltrials |
| NCT02498665 | A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies | completed | Phase 1 | 24 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02264665 | OPALINE : A Study Of Morbidity And Mortality At 2 Years(OPALINE) | completed | — | 144 | PfizerINDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT04281511 | A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy | completed | — | 238 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06129812 | An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer | completed | — | 1,132 | Seoul National University HospitalOTHER | 0 | Nov 13, 2023 | clinicaltrials |
| NCT05528614 | Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.(ReSiPaTNE) | completed | — | 51 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT02178436 | Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Mohammed Najeeb Al HallakOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT03304210 | PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer(PIPAC-nabpac) | completed | Phase 1 | 20 | University Hospital, GhentOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT04210128 | Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment | completed | — | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT00020345 | Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04257955 | COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer(COMMUNICARE) | completed | — | 32 | IRCCS San RaffaeleOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT02243358 | Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer | completed | Phase 2 | 24 | Henry Ford Health SystemOTHER | 1 | Oct 27, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Feb 26, 2024source: clinicaltrials